19 results

• Pfizer Settles Oxbryta Lawsuit Over Child’s Vaso-Occlusive Crises (VOCs) Linked To Recalled Drug

  June 23, 2026

  Irvin Jackson

  Oxbryta’s manufacturers say they have reached a proposed settlement to resolve a lawsuit filed by a mother whose child was hospitalized with VOCs, the same painful sickle cell complications the drug was intended to prevent.

• Oxbryta Lawsuit Settlement Terms Still Being Finalized

  February 18, 2026

  Irvin Jackson

  Plaintiffs and defendants involved in an Oxbryta wrongful death lawsuit asked a federal judge for more time to finalize negotiations on a settlement agreement.

• Oxbryta Settlement Reached by Pfizer To Resolve Vaso-Occlusive Crisis Lawsuit

  November 6, 2025

  Irvin Jackson

  Parties involved in an Oxbryta wrongful death lawsuit say they are close to finalizing a settlement agreement which would eliminate the need for a trial.

• Oxbryta Wrongful Death Lawsuit Set for Trial in Sept. 2027

  July 24, 2025

  Irvin Jackson

  A federal judge has set an Oxbryta wrongful death lawsuit to go to trial in September 2027 over claims that the recalled drug causes the very sickle cell symptoms it was supposed to prevent.

• Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025

  July 8, 2025

  Irvin Jackson

  A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients.

• Wrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises

  June 5, 2025

  Irvin Jackson

  A wrongful death lawsuit claims a Tennessee man suffered severe Oxbryta side effects, leading to stroke, complications and death.

• Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs

  May 23, 2025

  Irvin Jackson

  A New Jersey man claims that he was hospitalized multiple times due to problems caused by the recalled sickle cell disease drug, Oxbryta.

• First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks

  May 9, 2025

  Irvin Jackson

  An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers.

• Malpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death

  April 15, 2025

  Irvin Jackson

  The wife of a man who allegedly died from side effects of Oxbryta has brought claims against both the makers of the recalled sickle cell treatment and the medical staff who treated him.

• At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics

  March 14, 2025

  Irvin Jackson

  Plaintiffs and defendants report that at least eight Oxbryta lawsuits have been filed after the drug was recently pulled from the market due to sickle cell-related complications.